Showing results (161-170 of 226) with videos related to
Sort By:
Pageof 23
Japanese Journal of Clinical Oncology|April 12, 2002
A feasibility study of paclitaxel 225 mg/m(2) and carboplatin AUC = 6 in untreated advanced non-small cell lung cancer patients in JapanMitsumasa Ogawara, Masaaki Kawahara, Shigeto Hosoe, et al.Modern Rheumatology|October 17, 2015
Post-hoc analysis showing better clinical response with the loading dose of certolizumab pegol in Japanese patients with active rheumatoid arthritisTsutomu Takeuchi, Kazuhiko Yamamoto, Hisashi Yamanaka, et al.Heart and Vessels|May 26, 2019
Clinical risk factors of stroke and major bleeding in patients with non-valvular atrial fibrillation under rivaroxaban: the EXPAND Study sub-analysisIchiro Sakuma, Shinichiro Uchiyama, Hirotsugu Atarashi, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 15, 2004
Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trialYoshiki Yui, Tetsuya Sumiyoshi, Kazuhisa Kodama, et al.Journal of the Neurological Sciences|October 10, 2009
Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: results from 1-year outcomes in the Japanese REACH RegistryShinichiro Uchiyama, Shinya Goto, Masayasu Matsumoto, et al.International Heart Journal|November 10, 2015
Effect of a Low-Intensity Pulsed Ultrasound Device, SX-1001, on Clinical Symptoms in Buerger Disease With Limb IschemiaYukihito Higashi, Nobuyoshi Azuma, Yasuchika Takeishi, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 11, 2004
Nifedipine retard was as effective as angiotensin converting enzyme inhibitors in preventing cardiac events in high-risk hypertensive patients with diabetes and coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) subgroup analysisYoshiki Yui, Tetsuya Sumiyoshi, Kazuhisa Kodama, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|June 26, 2007
Prevalence, awareness and treatment of cardiovascular risk factors in patients at high risk of atherothrombosis in JapanTsutomu Yamazaki, Shinya Goto, Hiroshi Shigematsu, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|May 10, 2002
Dobutamine stress radionuclide ventriculography reveals silent myocardial dysfunction in Kawasaki diseaseYuji Hamamichi, Fukiko Ichida, Shinichi Tsubata, et al.Modern Rheumatology|December 10, 2013
Efficacy and safety of certolizumab pegol plus methotrexate in Japanese rheumatoid arthritis patients with an inadequate response to methotrexate: the J-RAPID randomized, placebo-controlled trialKazuhiko Yamamoto, Tsutomu Takeuchi, Hisashi Yamanaka, et al.Pageof 23